Solomon Cristina, Winterhalter Michael, Gilde Isabel, Hoy Ludwig, Calatzis Andreas, Rahe-Meyer Niels
Department of Anesthesiology, Hannover Medical School, Hannover, Germany;
Med Devices (Auckl). 2008 Jul;1:23-30. doi: 10.2147/mder.s3288. Epub 2008 Oct 9.
The standard method of assessment of platelet function is represented by light transmission aggregometry (LTA), performed in citrated platelet-rich plasma (PRP). With LTA, decrease and subsequent post-cardiopulmonary bypass (CPB) recovery of platelet function have been reported during cardiac surgery. Multiple electrode aggregometry (MEA) may be used as point-of-care method to monitor perioperative changes in platelet function. Since MEA assesses macroaggregation which is influenced by the plasmatic levels of unbound calcium, citrate may be inadequate as anticoagulant for MEA. We used citrate and heparin for MEA samples, to see with which anticoagulant the intraoperative decrease and postoperative recovery in platelet function previously described with other aggregometric methods in cardiac surgery may be observed with MEA.
Blood was obtained from 60 patients undergoing routine cardiac surgery and the samples were collected in standard tubes containing unfractionated heparin (50 U/mL) or trisodium citrate (3.2%). The samples were obtained before CPB, at 30 minutes on CPB, end of CPB and on the first postoperative day. MEA was performed using the Multiplate® analyzer. Collagen (COLtest, 100 μg/mL) and TRAP-6 (thrombin receptor activating peptide, TRAPtest, 1mM/mL) were used as aggregation agonists.
Platelet aggregometric response decreased significantly during CPB. Platelet aggregation assessed using TRAP-6 as agonist on heparinized blood significantly correlated with the duration of CPB (r = -0.41, p = 0.001, 2-tailed Pearson test). The aggregometric analysis performed on the first postoperative day showed a significant recovery in platelet activity in the samples containing heparin (increase from 30 ± 22 U to 46 ± 27 U for the COLtest and from 70 ± 34 U to 95 ± 32 U for the TRAPtest, p < 0.001, Student's t-test), while no significant recovery of platelet function could be established in the MEA measurements performed with citrated blood.
The choice of blood sample anticoagulant used for impedance aggregometry influenced the platelet aggregation response. Postoperative platelet function recovery was only detected in the heparinized samples. Heparin seems to be better suited than citrate for the analysis of impedance aggregometry in heart surgery.
血小板功能评估的标准方法是在枸橼酸化富血小板血浆(PRP)中进行的光透射聚集法(LTA)。据报道,在心脏手术期间,使用LTA可观察到血小板功能降低以及随后的体外循环(CPB)后恢复情况。多电极聚集法(MEA)可作为一种床旁检测方法,用于监测围手术期血小板功能的变化。由于MEA评估的是受游离钙血浆水平影响的大聚集体,枸橼酸盐可能不足以作为MEA的抗凝剂。我们将枸橼酸盐和肝素用于MEA样本,以观察使用MEA能否观察到心脏手术中先前用其他聚集法描述的血小板功能术中降低和术后恢复情况。
从60例行常规心脏手术的患者中采集血液,样本收集于含有普通肝素(50 U/mL)或枸橼酸钠(3.2%)的标准试管中。在CPB前、CPB 30分钟时、CPB结束时及术后第一天采集样本。使用Multiplate®分析仪进行MEA检测。胶原(COLtest,100 μg/mL)和TRAP-6(凝血酶受体激活肽,TRAPtest,1 mM/mL)用作聚集激动剂。
在CPB期间,血小板聚集反应显著降低。以TRAP-6为激动剂对肝素化血液进行的血小板聚集评估与CPB持续时间显著相关(r = -0.41,p = 0.001,双尾Pearson检验)。术后第一天对样本进行的聚集分析显示,含肝素样本中的血小板活性有显著恢复(COLtest从30±22 U增加到46±27 U,TRAPtest从70±34 U增加到95±32 U,p < 0.001,Student t检验),而用枸橼酸化血液进行的MEA测量中未发现血小板功能有显著恢复。
用于阻抗聚集法的血样抗凝剂选择会影响血小板聚集反应。仅在肝素化样本中检测到术后血小板功能恢复。在心脏手术中,肝素似乎比枸橼酸盐更适合用于阻抗聚集法分析。